Viewing Study NCT00501605


Ignite Creation Date: 2025-12-25 @ 3:10 AM
Ignite Modification Date: 2026-03-30 @ 9:33 AM
Study NCT ID: NCT00501605
Status: COMPLETED
Last Update Posted: 2011-01-21
First Post: 2007-07-13
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I Study With AZD2171 in Patients With Advanced Solid Malignant Tumors and Liver Metastases
Sponsor: AstraZeneca
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Solid Tumor View
None Liver Metastases View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Phase I View
None AZD2171 View
None advanced solid tumors View